Short-chain fatty acids in clinical practice: where are we?
- 27 December 2024
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 28 (2) , 54-60
Abstract
Purpose of review: Once considered to have only local influences on the gut mucosa, short-chain fatty acids (SCFAs) now appear to have a much wider anti-inflammatory, immune-modulating, systemic effect. This article reviews recent evidence to suggest a much wider clinical application of this valued dietary substrate. Recent findings: SCFAs act systemically through stimulation of G protein receptors (GPRs) and inhibition of histone deacetylases (HDACs). SCFAs cause appetite suppression, reduce systemic inflammation, improve insulin sensitivity, increase energy expenditure, promote mitochondrial function, stimulate satiety, reduce blood pressure, and improve cognitive function from various neurologic maladies. Summary: Dietary strategies should be implemented to provide this beneficial substrate across a wide spectrum of disease conditions. Use of prebiotic fiber or liquid supplements containing high SCFA-producing organisms should be considered as therapeutic targets for multiple metabolic, immunologic, and neurodegenerative diseases.Keywords
This publication has 34 references indexed in Scilit:
- Short-chain fatty acids: Important components of the gut-brain axis against ADBiomedicine & Pharmacotherapy, 2024
- Gut microbiota, intestinal permeability, and systemic inflammation: a narrative reviewInternal and Emergency Medicine, 2023
- Short-chain fatty acids in cancer pathogenesisCancer and Metastasis Reviews, 2023
- PYY (3-36) protects against high fat feeding induced changes of pancreatic islet and intestinal hormone content and morphometryBiochimica et Biophysica Acta (BBA) - General Subjects, 2023
- GLP-1 receptor agonist liraglutide exerts central action to induce β-cell proliferation through medulla to vagal pathway in miceBiochemical and Biophysical Research Communications, 2018
- Short‐Chain Fatty Acid Transporters: Role in Colonic Homeostasis2017
- Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocationFree Radical Biology and Medicine, 2016
- Evidence for glucagon-like peptide-1 receptor signaling to activate ATP-sensitive potassium channels in pancreatic beta cellsBiochemical and Biophysical Research Communications, 2016
- The Gut Hormones PYY3-36 and GLP-17-36 amide Reduce Food Intake and Modulate Brain Activity in Appetite Centers in HumansCell Metabolism, 2011
- Peptide YY Is Critical for Acylethanolamine Receptor Gpr119-Induced Activation of Gastrointestinal Mucosal ResponsesCell Metabolism, 2010